Loading clinical trials...
Loading clinical trials...
The purpose of the study is to compare time to progression and overall survival after treatment with Taxotere plus cisplatin versus cisplatin plus 5-FU (PF treatment group) in the first line treatment...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Sanofi
NCT03429036 · Hearing Disorder, Oral Mucosal Disease, and more
NCT07174336 · Breast Neoplasms, Neoplasm Metastasis
NCT07213804 · Ovarian Neoplasms, Fallopian Tube Neoplasms, and more
NCT07046923 · Carcinoma, Non-Small-Cell Lung, Small Cell Lung Carcinoma, and more
NCT05544136 · Head and Neck Cancer, Head and Neck Carcinoma, and more
sanofi-aventis US
Bridgewater, New Jersey
Sanofi-Aventis
Buenos Aires
sanofi-aventis, Australia
Macquarie Park, New South Wales
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions